Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
52,870,098
-
Total 13F shares
-
44,931,048
-
Share change
-
-1,315,829
-
Total reported value
-
$465,320,127
-
Put/Call ratio
-
88%
-
Price per share
-
$10.36
-
Number of holders
-
185
-
Value change
-
-$16,658,400
-
Number of buys
-
83
-
Number of sells
-
102
Institutional Holders of Emergent BioSolutions Inc. - COMMON STOCK (EBS) as of Q1 2023
As of 31 Mar 2023,
Emergent BioSolutions Inc. - COMMON STOCK (EBS) was held by
185 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
44,931,048 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, DIMENSIONAL FUND ADVISORS LP, D. E. Shaw & Co., Inc., JACOBS LEVY EQUITY MANAGEMENT, INC, HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC, GOLDMAN SACHS GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, and Invesco Ltd..
This page lists
187
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.